Search by Drug Name or NDC
NDC 63561-0178-02 Astringent 1347; 952 mg/2299mg; mg/2299mg Details
Astringent 1347; 952 mg/2299mg; mg/2299mg
Astringent is a TOPICAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Granulation Technology, Inc.. The primary component is ALUMINUM SULFATE TETRADECAHYDRATE; CALCIUM ACETATE MONOHYDRATE.
Product Information
| NDC | 63561-0178 |
|---|---|
| Product ID | 63561-0178_06e6abb2-42ec-5536-e063-6394a90a8a79 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Astringent |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | POWDER, FOR SOLUTION |
| Route | TOPICAL |
| Active Ingredient Strength | 1347; 952 |
| Active Ingredient Units | mg/2299mg; mg/2299mg |
| Substance Name | ALUMINUM SULFATE TETRADECAHYDRATE; CALCIUM ACETATE MONOHYDRATE |
| Labeler Name | Granulation Technology, Inc. |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part347 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63561-0178-02 (63561017802)
| NDC Package Code | 63561-0178-2 |
|---|---|
| Billing NDC | 63561017802 |
| Package | 12 PACKET in 1 CARTON (63561-0178-2) / 2299 mg in 1 PACKET (63561-0178-1) |
| Marketing Start Date | 2023-10-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |